Clinicopathological Study of Primary Central Nervous System Lymphomas in Patients Referred to Hospitals of Shahid Sadoughi University, Yazd from 2011 to 2016

Document Type : Original Article

Authors

1 Professor of Pathology.Department of Pathology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

2 Medical Student, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Abstract

Background and Objective: Primary central nervous system lymphoma is a rare, extra-nodal non‐Hodgkin's lymphoma. It commonly involves brain, meninges or eyes. In this study, we investigated its clinicopathological features and survival rate in Yazd.
Subjects and Methods:  All samples related to the central nervous system lymphomas were extracted from 2011 to 2016 at Pathology Department of Shahid Sadoughi University of Medical Sciences, Yazd, Iran. They were registered in the pre-designed check-lists. Survival rates were evaluated by referring to the physicians' offices, and also by calling on the patients.
Subjects and Methods:  All samples related to the central nervous system lymphomas were extracted from 2011 to 2016 at Pathology Department of Shahid Sadoughi University of Medical Sciences, Yazd, Iran. They were registered in the pre-designed check-lists. Survival rates were evaluated by referring to the physicians' offices, and also by calling on the patients.
Results: The present study was performed on 15 patients with primary central nervous system lymphoma including 7 males (46.7%) and 8 females (53.3%). The most common clinical presentations were motor deficits (33.3%), increased intra-cranial pressure (26.7%) and seizure (20%) respectively. All cases were diffuse large B-cell lymphoma, and high grade in 13.3% of cases. In most of cases (80%), the lesion was in one of the cerebral hemispheres. The most frequent sites were the temporal and parietal lobe.
Conclusion: Primary central nervous system lymphoma is a rare, invasive, extra-nodal non‐Hodgkin's lymphoma. In our study, its clinicopathological feature was similar to the other studies. The mean survival rate in patients with immune-deficiency was not significantly different from patients without immune-deficiency.

Keywords

References

1-Dalia S, Forsyth P, Chavez J, Price S, Shah B, Bello C, Sokol L, Pan E, Sotomayor E, Lee JH, Fisher K, Jaglal M.Primary B-cell CNS lymphoma clinicopathologic and treatment outcomes in 89 patients from a single tertiary care center.Int J Hematol. 2014 Apr;99(4):450-6
2-Hoang-Xuan K, Bessell E, Bromberg J, Hottinger AF, Preusser M, Rudà R, Schlegel U, Siegal T, Soussain C, Abacioglu U, Cassoux N, Deckert M, Dirven CM, Ferreri AJ, Graus F, Henriksson R, Herrlinger U, Taphoorn M, Soffietti R, Weller M; European Association for Neuro-Oncology Task Force on Primary CNS Lymphoma.Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology.Lancet Oncol. 2015 Jul;16(7):e322-32
3- RamachandranTS , BermanSA.Primary CNS Lymphoma. Medscape,Updated: Dec 11, 201
4-Schäfer N, Glas M, Herrlinger U.Primary CNS lymphoma: a clinician's guide.Expert Rev Neurother. 2012 Oct;12(10):1197-206
5-Phillips EH1, Fox CP, Cwynarski K.Primary CNS lymphoma.CurrHematolMalig Rep. 2014 Sep;9(3):243-53
6- Robbins Stanley L,etal,Basic Pathology.9thedition.W.B Saunders.2013
7- Szczepanek D, Wąsik-Szczepanek E, Stoma F, Sokołowska B, Trojanowski T.Primary central nervous system lymphoma as a neurosurgical problem.NeurolNeurochir Pol. 2017 Jul - Aug;51(4):319-323
8- Schultz CJ, Bovi J.Current management of primary central nervous system lymphoma.Int J RadiatOncolBiol Phys. 2010 Mar 1;76(3):666-78
9-Yun J, Iwamoto FM, Sonabend AM.Primary Central Nervous System Lymphoma: A Critical Review of the Role of Surgery for Resection.Arch Cancer Res. 2016;4(2). pii: 71
10-Korfel A, Weller M, Martus P, Roth P, Klasen HA, Roeth A, Rauch M, Hertenstein B, Fischer T, Hundsberger T, Leithäuser M, Birnbaum T, Kirchen H, Mergenthaler HG, Schubert J, Berdel W, Birkmann J, Hummel M, Thiel E, Fischer L.Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial.Ann Oncol. 2012 Sep;23(9):2374-80
11-Montserrat E.Primary CNS lymphoma: in search of the evidence.Lancet Haematol. 2015 Jun;2(6):e227-8
12-Ney DE, Reiner AS, Panageas KS, Brown HS, DeAngelis LM, Abrey LE.Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience.Cancer. 2010 Oct 1;116(19):4605-12
13-Roth P, Hoang-Xuan K.Challenges in the treatment of elderly patients with primary central nervous system lymphoma.CurrOpin Neurol. 2014 Dec;27(6):697-701
14-Patel B, Chacko G, Nair S, Anandan J, Chacko AG, Rajshekhar V, Turel M.Clinicopathological correlates of primary central nervous system lymphoma: Experience from a tertiary care center in South India. Neurol India. 2015 .NO:63(1).P:77-82.
15-Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ. Primary central nervous system lymphoma--a report of 32 cases with literature review. Ai Zheng. 2006.NO:25(4).P:476-80
16-Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M, Guy G, Lapierre F.Primary intracerebral malignant lymphoma: report of 248 cases.J Neurosurg. 2000 Feb;92(2):261-6
17-Abla O, Weitzman S, Blay JY, O'Neill BP, Abrey LE, Neuwelt E, Doolittle ND, Baehring J, Pradhan K, Martin SE, Guerrera M, Shah S, Ghesquieres H, Silver M, Betensky RA, Batchelor T.Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).Clin Cancer Res. 2011 Jan 15;17(2):346-52
Jundishapur Scientific Medical Journal
Volume 17, Issue 3 - Serial Number 114
September and October 2018
Pages 303-314

Files

History

  • Receive Date: 11 April 2018
  • Revise Date: 03 September 2018
  • Accept Date: 08 September 2018

Share

How to cite

Statistics